retatrutide latest clinical trial results

retatrutide latest clinical trial results Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a Retatrutide, Eli Lilly's next obesity

Name: retatrutide latest clinical trial results Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a Retatrutide, Eli Lilly's next obesity
Brand: treasurenottrashrecycling.com
SKU: 3240297123
Price: 29.14 USD
Availability: InStock
Rating: 4.1872 (25 reviews)

SKU: 3240297123

4.2

EUR29.14 EUR55.14

Pay in 4 interest-free payments of $7.29 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 19 - Aug 24

Description

Sold strictly for laboratory research use only

Individuals with a personal or family history of thyroid tumours should be aware that, in common with other GLP-1 receptor agonists, retatrutide's GLP-1 activity may carry a theoretical thyroid risk